Form 8-K BIOGEN INC. For: Jan 29

Go back to Form 8-K BIOGEN INC. For: Jan 29

Biogen (BIIB) PT Lowered to $337 at RBC Capital

January 30, 2019 6:25 AM EST

RBC Capital analyst Brian Abrahams lowered the price target on Biogen (NASDAQ: BIIB) to $337.00 (from $342.00) while maintaining a Sector Perform rating.

... More

Biogen (BIIB) PT Raised to $380 at Oppenheimer

January 29, 2019 5:29 PM EST

Oppenheimer analyst Jay Olson raised the price target on Biogen (NASDAQ: BIIB) to $380.00 (from $372.00) while maintaining a Outperform rating.

Olson noted an 'impressive' Q4 performance which featured a business update that perplexed investors with plans for an intriguing Alzheimer's prevention study.

... More